Back to search

University of Edinburgh

Fertility in childhood cancer survivors

Abstract

dc:description.abstract

Childhood cancer survival rates have increased over recent decades, with over 80% of children diagnosed with cancer in the UK now surviving over five years from diagnosis. As such, there is an increasing population of childhood cancer survivors living with the long-term sequelae of their treatment. One such consequence is potential loss of fertility, which is significant source of anxiety for patients and families. As such, it is recommended that at the time of cancer diagnosis, potential impact of treatment on fertility should be discussed with patients and their families, and fertility preservation should be offered to eligible patients at high risk of future infertility. Fertility preservation options are more limited for pre- than post-pubertal patients. For post-pubertal males, cryopreservation of semen is a well-established, non-invasive technique that should be offered. Post-pubertal females can cryopreserve mature oocytes. For patients in a relationship, embryos can be cryopreserved. However, these techniques cannot be offered prior to puberty. Females can be offered cryopreservation and ultimate autotransplantation of ovarian tissue. This technique is also offered to adult females and has resulted in over 200 live births worldwide; however, the vast majority of these have been from patients whose tissue was cryopreserved post-pubertally. As such, there remains limited evidence for this technique in pre-pubertal patients. Pre-pubertal male patients can be offered cryopreservation of testicular tissue, but this technique has not yet been demonstrated to restore fertility in human males and is therefore entirely experimental. Given the significance of future fertility for childhood cancer survivors and the limited options for fertility preservation in this patient group, this thesis aims to explore the effect of chemotherapy drugs on the pre-pubertal testis and to examine current practices in fertility preservation for this patient group. To do this, I have primarily employed several techniques: in vitro tissue culture, systematic literature review, clinical data analysis, audit, and surveys. In order to further understand the mechanisms by which fertility is impaired, this thesis explores the effect of chemotherapy drugs administered on the pre-pubertal testis through an in vitro mouse tissue culture model, with particular focus on the anthracycline doxorubicin and the alkylating agents ifosfamide and cyclophosphamide. Results of my work with doxorubicin aimed to investigate the effect of repeated exposures to a chemotherapy drug, given that this is how these drugs are administered in practice. Results showed no significant difference between tissue treated with a single full dose or two half doses, suggesting the cumulative exposure is more important to outcome. However, there were differences seen in tissue treated with the same concentration at different time points in the culture model, suggesting perhaps a developmental difference in the tissue or an effect of duration of in vitro culture. Further work, including in vivo investigation and clinical follow-up, is necessary to further investigate the effect of these drugs administered pre-pubertally. My results indicate that the alkylating agents ifosfamide and cyclophosphamide damage the germ cells and specifically the spermatogonial stem cells, which are necessary for future spermatogenesis, of the immature testis. The supporting somatic cells were relatively spared from damage, with only the highest concentration of the cyclophosphamide metabolite causing a reduction in Sertoli cell density. A systematic review of the effects of ifosfamide and cyclophosphamide on the pre-pubertal testis demonstrates that there are less published data about the effect of treatment with ifosfamide in childhood on long term male reproductive outcomes. Treatment with cyclophosphamide was associated with a dose-dependent reduction in sperm count and increase in follicle-stimulating hormone level, indicating impaired spermatogenesis. Given the importance of offering fertility preservation to eligible patients, I have undertaken an audit of paediatric oncology treatment centres and a survey of reproductive medicine units in the U.K. that receive referrals for this patient cohort. The results of the audit demonstrate that fertility is not being discussed with all childhood cancer survivors and also identify potential barriers to offering and accepting fertility preservation, including patient age and urgency to start treatment. The survey findings suggest that cryopreservation of gametes is more well-established than cryopreservation of gonadal tissue. Additionally, there are regional variations in availability and funding of fertility preservation techniques for pre-pubertal patients. This is a dynamic area, with regards to scientific and clinical advances in use of stored gonadal tissue for fertility restoration, as well as with regards to how these services are being funded and appointed in the U.K. As such, ongoing assessment of provision of services is required. To validate the current eligibility criteria for ovarian tissue cryopreservation, I have assessed clinical follow-up data for a cohort of female patients diagnosed with childhood cancer in South-East Scotland. My findings suggest that the current eligibility criteria are valid for selecting patients at highest risk of premature ovarian failure, but highlight important issues of disease relapse and of the need to optimise reproductive follow-up in this cohort. While testicular tissue cryopreservation remains experimental, it is a procedure which is increasingly being offered worldwide. In this thesis, I present data from an international survey of centres which are currently offering immature testicular tissue cryopreservation, to summarise current practice and consider recommendations. Overall, these results contribute to an understanding of the effects of chemotherapy on the pe-pubertal testis, summarise current practice in fertility preservation for childhood cancer patients in the UK and worldwide, and identify challenges which need to be addressed.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Duffin, Kathleen
Advisors dc:contributor.advisor
  • Spears, Norah
  • Mitchell, Rod
  • Lopes, Federica
  • Gourley, Charlie

Subjects

dc:subject × 5

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
University of Edinburgh
Base URL
era.ed.ac.uk/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Duffin, Kathleen. Fertility in childhood cancer survivors. 2026. https://era.ed.ac.uk/handle/1842/44523